|
|
|
Volumn 18, Issue 14 Suppl 14, 2004, Pages 26-34
|
|
Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROURACIL;
FOLFOX PROTOCOL;
FOLINIC ACID;
IFL PROTOCOL;
IRINOTECAN;
PLATINUM COMPLEX;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
HUMAN;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 17944376451
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (43)
|
